Adherence to nicotine replacement patch therapy in cardiovascular patients

International Journal of Behavioral Medicine

Volumn 13, Issue 1, 2006, Pages 79-88

  Wiggers, Louise C W ^a   Smets, Ellen M A ^a   Oort, Frans J ^a   Storm Versloot, Marja N ^a   Vermeulen, Hester ^a   Van Loenen, Lucas B M ^a   Peters, Ron J G ^a   De Haes, Hanneke C J M ^a   Legemate, Dink A ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Adherence; Cardiovascular disease; NRT; Smoking cessation

Indexed keywords

NICOTINE; GANGLION STIMULATING AGENT;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CIGARETTE SMOKING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DEPRESSION; DIARRHEA; DIZZINESS; FEMALE; HEADACHE; HEALTH CARE ACCESS; HUMAN; MAJOR CLINICAL STUDY; MALE; NICOTINE REPLACEMENT THERAPY; PATIENT ASSESSMENT; PATIENT COMPLIANCE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SMOKING CESSATION; SOCIAL BEHAVIOR; TOBACCO DEPENDENCE; WITHDRAWAL SYNDROME; INTRADERMAL DRUG ADMINISTRATION; METHODOLOGY; MIDDLE AGED; NETHERLANDS; SMOKING;

ADMINISTRATION, CUTANEOUS; CARDIOVASCULAR DISEASES; FEMALE; GANGLIONIC STIMULANTS; HUMANS; MALE; MIDDLE AGED; NETHERLANDS; NICOTINE; PATIENT COMPLIANCE; SMOKING; SMOKING CESSATION;

EID: 33645972961     PISSN: 10705503     EISSN: None     Source Type: Journal    
DOI: 10.1207/s15327558ijbm1301_10     Document Type: Article

References (45)

1. Abelin, T., Buehler, A., Müller, P., Vesanen, K., & Imhof, P. R. (1989). Controlled trial of transdermal nicotine patch in tobacco withdrawal. The Lancet, 1, 7-10.
2. The Agency for Health Care Policy and Research Smoking Cessation Clinical Practice Guideline. (1996). JAMA, 275(16), 1270-1280.
3. Alterman, A. I., Gariti, P., Cook, T. G., & Cnaan, A. (1999). Nicodermal patch adherence and its correlates. Drug & Alcohol Dependence, 53, 159-165.
4. Bolliger, C. T., Zellweger, J. P., Danielsson, T., van Biljon, X., Robidou, A., Westin, A., et al. (2000). Smoking reduction with oral nicotine inhalers: Double blind, randomised clinical trial of efficacy and safety. British Medical Journal, 321, 329-333.
5. Bolman, C., De Vries, H., & Van Breukelen, G. A. (2002). Minimal-contact intervention for cardiac inpatients: Long-term effects on smoking cessation. Preventive Medicine, 35, 181-192.
6. Burling, T., Singleton, E., Bigelow, G., Baile, W. F., Gottlieb, S. H. (1984). Smoking following myocardial infarction: A critical review of the literature. Health Psychology, 3, 83-86.
7. Cheng, J. W. M., & Feifer, S. F. (2001). Patient-reported adherence to guidelines of the sixth joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Pharmacotherapy, 21, 828-841.
8. Chesney, M. A., Ickovics, J. R., Cahnbers, D. B., Gifford, A. L., Neidig, J., Zwickl, B., et al. (2000). Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: The AACTG adherence instruments. Patient Care Committee & Adherence Working Group of the Outcomes Committee of the Adult AIDS Clinical Trials Group (AACTG). AIDS Care, 12(3), 255-266.
9. Cohen, J. (1988). Statistical power analyses for the behavioral sciences. Hillsdale, NJ: Lawrence Erlbaum Associates, Inc.
10. Crouse, J. R., & Hagaman, A. P. (1991). Smoking cessation in relation to cardiac procedures. American Journal of Epidemiology, 134, 699-703.
11. Cummings, K. M., Biernbaum, R. P., Zevon, M. A., Delourghry, T., & Jaen, C. R. (1994). Use and effectiveness of transdermal nicotine in primary care settings. Archives of Family Medicines, 3, 682-689.
12. DiClemente, C. C., Prochaska, J. O., Fairhurst, S. K., Velicer, W. F., Velasquez, M. M., & Rossi, J. S. (1991). The process of smoking cessation: An analysis of pre-contemplation, contemplation, and preparation stages of change. Journal of Consulting and Clinical Psychology, 59, 295-304.
13. Dijkstra, A., De Vries, H., Roijackers, J., & Van Breukelen, G. (1998). Tailored interventions to communicate stage-matched information to smokers in different motivational stages. Journal of Consulting and Clinical Psychology, 3, 549-557.
14. Fagerström, K. O., Heatherton, T. F., & Kozlowski, L. T. (1990). Nicotine addiction and its assessment. Ear, Nose, & Throat Journal, 69(11), 763-765.
15. Fagerström, K. O., Tejding, R., Westin, A., & Lunell, E. (1997). Aiding reduction of smoking with nicotine replacement medications: Hope for the recalcitrant smoker? Tobacco Control, 6, 311-316.
16. Fiore, M. C., Jorenby, D. E., Baker, T. B., & Kenford, S. L. (1992). Tobacco dependence and the nicotine patch. Clinical guidelines for effective use. JAMA, 268(19), 2687-2694.
17. Fiore, M. C., Smith, S. S., Jorenby, D. E., & Baker, T. B. (1994). The effectiveness of the nicotine patch for smoking cessation. JAMA, 271(4), 1940-1944.
18. Fornai, E., Desideri, M., Pistelli, F., Carrozzi, L., Puntoni, R., Avino, S., et al. (2001). Smoking reduction in smokers compliant to a smoking cessation trial with nicotine patch. Monaldi Archive of Chest Disease, 56(1), 5-10.
19. Frid, D., Ockene, I., Ockene, J., Merriam, P., Goldberg, R., Kristeller, J., et al. (1991). Severity of angiographically proven coronary artery disease predicts smoking cessation. American Journal of Preventive Medicine, 7, 131-135.
20. Gourlay, S. G., Forbes, A., Marriner, T., Pethica, D., & McNeil, J. J. (1995). Double blind trial of repeated treatment with transdermal nicotine for relapsed smokers. British Medical Journal, 311, 363-366.
21. Heatherton, T. F., Kozlowski, L. T., Frecker, R. C., & Fagerström, K. O. (1991). The Fagerström Test for Nicotine Dependence: A revision of the Fagerström Tolerance Questionnaire. British Journal of Addiction, 86(9), 1119-1127.
22. Hobbs, S. D., & Bradbury, A. W. (2003). Smoking cessation strategies in patients with peripheral arterial disease: An evidence-based approach. European Journal of Vascular & Endovascular Surgery, 26(4), 341-347.
23. Hughes, J. R., Cummings, M., & Hyland, A. (1999) Ability of smokers to reduce their smoking and its association with future smoking cessation. Addiction, 94, 109-114.
24. Joseph, A. M., Norman, S. M., Ferry, L. H., Prochazka, A. V., Westman, E. C., Steele, B. G., et al. (1996). The safety of transdermal nicotine as an aid to smoking cessation in patients with cardiac disease. New England Journal of Medicine, 335, 1792-1798.
25. Kannel, W. B. (1994). Risk factors for atherosclerotic cardiovascular outcomes in different arterial territories. Journal of Cardiovascular Risk, 1, 333-339.
26. Kenford, S. L., Fiore, M. C., Jorenby, D. E., Smith, S. S., Wetter, D., & Baker, T. B. (1994). Predicting smoking cessation. Who will quit with and without the nicotine patch. JAMA, 271(8), 589-594.
27. Mahrer-Imhof, R., Froelicher, E. S., Li, W. W., Parker, K. M., & Benowitz, N. (2002). Women's initiative for non-smoking (WINS V): Under-use of nicotine replacement therapy. Heart & Lung, 31(5), 368-373.
28. May, S., West, R., Hajek, P., Nilsson, F., Foulds, J., & Meadow, A. (2003). The use of videos to inform smokers about different nicotine replacement products. Patient Education and Counseling, 51, 143-147.
29. Mudde, A. N., Willemsen, M. C., Kremers, S., & de Vries, H. (2000). Meetinstrumenten voor onderzoek naar roken en stoppen met roken [Measurements for research on smoking and quitting]. The Hague, Netherlands: STIVORO.
30. Murray, M., Swan, A. V., Kiryluk, S., & Clarke, G. C. (1988). The Hawthorne effect in the measurement of adolescent smoking. Journal of Epidemiology and Community Health, 42(3), 304-306.
31. Nieuwkerk, P. T., Sprangers, M. A., Burger, D. M., Hoetelmans, R. M., Hugen, P. W., Danner, S. A., et al. (2001). Limited patient adherence to highly active antiretroviral therapy for HlV-1 infection in an observational cohort study. Archives of Internal Medicine, 161(16), 1962-1968.
32. Piasecki, T. M., Fiore, M. C., & Baker, T. B. (1997). Profiles in discouragement: Two studies of variability in the time course of smoking withdrawal symptoms. Journal of Abnormal Psychology, 107(2), 238-251.
33. Pieterse, M. E., Seydel, E. R., De Vries, H., Mudde, A. N., & Kok, G. J. (2001). Effectiveness of a minimal contact smoking cessation program for Dutch general practitioners: A randomised controlled trial. Preventive Medicine, 32(2), 182-190.
34. Sastre Toraňo, J., & van Kan, H. J. M. (2003). Simultaneous determination of the tobacco smoke uptake parameters nicotine, cotinine and thiocyanate in urine, saliva and hair, using gas chromatography-mass spectrometry for characterization of smoking status of recently exposed subjects. Analyst, 128, 838-843.
35. Silagy, C., Lancaster, T., Stead, L., Mand, D., & Fowler, G. (2002). Nicotine replacement therapy for smoking cessation. In: The Cochrane Library. Oxford: Update Software, 2002: issue 4.
36. Stapleton, J. A., Russell, M. A., Feyerabend, C., Wiseman, S. M., Gustavsson, G., Sawe, U., et al. (1995). Dose effects and predictors of outcome in a randomized trial of transdermal nicotine patches in general practice. Addiction, 90, 31-42.
37. Svarstad, B. L., Chewning, B. A., Sleath, B. L., & Claesson, C. (1999). The brief medication questionnaire: A tool for screening patient adherence and barriers to adherence. Patient Education and Counseling, 37(2), 113-124.
38. Tønnessen, P., Nørregaard, J., Simonsen, K., & Sawe, U. (1991). A double-blind trial of a 16-hour transdermal nicotine patch in smoking cessation. The New England Journal of Medicine. 325(5), 311-315.
39. Tzivoni, D., Keren, A., Meyler, S., Khoury, Z., Lerer, T., & Brunel, P. (1998). Cardiovascular safety of transdermal nicotine patches in patients with coronary artery disease who try to quit smoking. Cardiovascular Drugs and Therapy, 12, 239-244.
40. U.S. Department of Health and Human Services. (1983). The health consequences of smoking: Cardiovascular disease. A report of the Surgeon General. Rockville, MD: Author.
41. Velicer, W. F., Prochaska, J. O., Fava, J. L., Rossi, J. S., Redding, C. A., Laforge, R. G., et al. (2000). Using the transtheoretical model for population-based approaches to health promotion and disease prevention. Homeostasis, 40, 174-195.
42. Ward, M. M., Swan, G. E., & Jack, L. M. (2001). Self-reported abstinence effects in the first month after smoking cessation. Addictive Behaviors. 26(3), 311-327.
43. Wiggers, L. C. W., Smets, E. M. A., de Haes, J. C. J. M., Peters, R. J. G., & Legemate, D. A. (2003). Smoking cessation interventions in cardiovascular patients. European Journal of Vascular & Endovascular Surgery, 26(5), 467-475.
44. World Health Organization. (2003). Disease-specific reviews: Tobacco smoking cessation. In World Health Report Organization (Ed.), Adherence to long-term therapies: evidence for action (pp. 115-120). Geneva: Author.
45. Zevin, S., Peyton, J., & Benowitz, N. (1998). Dose-related cardiovascular and endocrine effects of transdermal nicotine. Clinical Pharmacology & Therapeutics, 64(1), 87-95.